CBD Life Sciences (CBD Life Sciences) Debt-to-Revenue : N/A (As of Sep. 2015)

View and export this data going back to 2009. Start your Free Trial

What is CBD Life Sciences Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

CBD Life Sciences's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2015 was $0.00 Mil. CBD Life Sciences's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2015 was $0.00 Mil. CBD Life Sciences's annualized Revenue for the quarter that ended in Sep. 2015 was $0.00 Mil.

CBD Life Sciences Debt-to-Revenue Historical Data

The historical data trend for CBD Life Sciences's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CBD Life Sciences Debt-to-Revenue Chart

CBD Life Sciences Annual Data

Trend

Dec11

Dec12

Dec13

Dec14

Debt-to-Revenue

N/A

CBD Life Sciences Quarterly Data
	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15
Debt-to-Revenue	Get a 7-Day Free Trial											N/A	-	N/A	N/A	N/A

Competitive Comparison of CBD Life Sciences's Debt-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, CBD Life Sciences's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CBD Life Sciences's Debt-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CBD Life Sciences's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where CBD Life Sciences's Debt-to-Revenue falls into.

CBD Life Sciences Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

CBD Life Sciences's Debt-to-Revenue for the fiscal year that ended in Dec. 2014 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(0	+	0)	/	0.123
	=	0.00

CBD Life Sciences's annualized Debt-to-Revenue for the quarter that ended in Sep. 2015 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(0	+	0)	/	0
	=	N/A

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Sep. 2015) Revenue data.

CBD Life Sciences Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of CBD Life Sciences's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

CBD Life Sciences (CBD Life Sciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CBD Life Sciences Inc (OTCPK:CBDL) » Definitions » Debt-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

10853 N. Frank Llyod Wright Boulevard, Suite 108, Scottsdale, AZ, USA, 85259

Website

https://lbcbioscienceinc.com

CBD Life Sciences Inc is developing and marketing a line of cannabidiol based organic products such as hemp drops, massage oils, recovery pain relief creams, anxiety and sleep solutions supplements, edibles, and a full line of pet products. The company is also in the process of developing an anti-aging skin product line.